Eli Lilly’s stock dives as Mounjaro and Zepbound sales miss, but Citi says buy

• Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

  Business - CNBC - 1 hour ago
• 

  Shares in weight-loss drugmaker Eli Lilly tumble on disappointing sales

  Business - Financial Times - 3 hours ago

• We're buying more of a stock that has gone on sale since reporting earnings

  Business - CNBC - October 14

• GE Aerospace’s stock sinks as total sales beat, but commercial engines miss

  Business - MarketWatch - October 22

• Honeywell’s stock falls as sales miss and lowered guidance offsets profit beat

  Business - MarketWatch - 6 days ago

More from MarketWatch

• Caterpillar’s stock falls as weak equipment sales lead to a rare profit miss

  Business - MarketWatch - 8 minutes ago

• The next recruiter to read your LinkedIn profile could be AI. Here’s what it’s looking for.

  Business - MarketWatch - 9 minutes ago

• U.K. government bond yields volatile as budget delivers £40 billion tax hike

  Business - MarketWatch - 23 minutes ago

• Super Micro’s troubles build as auditor resigns, sending stock tumbling 30%

  Business - MarketWatch - 43 minutes ago

• ‘Rocketship’ Reddit’s third-quarter results a real ‘Jekyll and Hyde’ story, says Bernstein

  Business - MarketWatch - 1 hour ago